Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm that treatment with IV ferric carboxymaltose improves
exercise capacity, physical functioning and quality of life in patients with iron deficiency
and chronic heart failure.